Human Gene CACNA1S (ENST00000362061.4_12) from GENCODE V47lift37
  Description: calcium voltage-gated channel subunit alpha1 S (from RefSeq NM_000069.3)
Gencode Transcript: ENST00000362061.4_12
Gencode Gene: ENSG00000081248.13_14
Transcript (Including UTRs)
   Position: hg19 chr1:201,008,640-201,081,554 Size: 72,915 Total Exon Count: 44 Strand: -
Coding Region
   Position: hg19 chr1:201,008,959-201,081,467 Size: 72,509 Coding Exon Count: 44 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsPathwaysOther NamesGeneReviewsModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr1:201,008,640-201,081,554)mRNA (may differ from genome)Protein (1873 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCHuman Cortex Gene ExpressionMalacardsMGIOMIMPubMed
ReactomeUniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: CAC1S_HUMAN
DESCRIPTION: RecName: Full=Voltage-dependent L-type calcium channel subunit alpha-1S; AltName: Full=Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle; AltName: Full=Voltage-gated calcium channel subunit alpha Cav1.1;
FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1S gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkylamines, benzothiazepines, and by omega-agatoxin-IIIA (omega-Aga-IIIA). They are however insensitive to omega-conotoxin- GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA (omega-Aga-IVA). Calcium channels containing the alpha-1S subunit play an important role in excitation-contraction coupling in skeletal muscle.
SUBUNIT: Multisubunit complex consisting of alpha-1, alpha-2, beta and delta subunits in a 1:1:1:1 ratio. The channel activity is directed by the pore-forming and voltage-sensitive alpha-1 subunit. In many cases, this subunit is sufficient to generate voltage-sensitive calcium channel activity. The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity. An additional gamma subunit is present only in skeletal muscle L-type channel. Interacts with DYSF and JSRP1. Interacts with RYR1 (By similarity).
SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
TISSUE SPECIFICITY: Skeletal muscle specific.
DOMAIN: Each of the four internal repeats contains five hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one positively charged transmembrane segment (S4). S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position.
DOMAIN: The loop between repeats II and III interacts with the ryanodine receptor, and is therefore important for calcium release from the endoplasmic reticulum necessary for muscle contraction.
PTM: Phosphorylation by PKA activates the calcium channel (By similarity).
DISEASE: Defects in CACNA1S are the cause of periodic paralysis hypokalemic type 1 (HOKPP1) [MIM:170400]; also designated HYPOPP. HOKPP1 is an autosomal dominant disorder manifested by episodic flaccid generalized muscle weakness associated with falls of serum potassium levels.
DISEASE: Genetic variations in CACNA1S are the cause of susceptibility to malignant hyperthermia 5 (MHS5) [MIM:601887]; an autosomal dominant disorder that is potentially lethal in susceptible individuals on exposure to commonly used inhalational anesthetics and depolarizing muscle relaxants.
DISEASE: Defects in CACNA1S are the cause of susceptibility to thyrotoxic periodic paralysis type 1 (TTPP1) [MIM:188580]. A sporadic muscular disorder characterized by episodic weakness and hypokalemia during a thyrotoxic state. It is clinically similar to hereditary hypokalemic periodic paralysis, except for the fact that hyperthyroidism is an absolute requirement for disease manifestation. The disease presents with recurrent episodes of acute muscular weakness of the four extremities that vary in severity from paresis to complete paralysis. Attacks are triggered by ingestion of a high carbohydrate load or strenuous physical activity followed by a period of rest. Thyrotoxic periodic paralysis can occur in association with any cause of hyperthyroidism, but is most commonly associated with Graves disease.
SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family. CACNA1S subfamily.
WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/CACNA1S";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: CACNA1S
Diseases sorted by gene-association score: hypokalemic periodic paralysis, type 1* (1682), malignant hyperthermia susceptibility 5* (875), thyrotoxic periodic paralysis 1* (594), periodic paralysis with transient compartment-like syndrome* (350), cacna1s-related malignant hyperthermia susceptibility* (100), thyrotoxic periodic paralysis* (64), malignant hyperthermia (41), central core disease (24), malignant hyperthermia susceptibility (20), malignant hyperthermia of anesthesia* (18), hypokalemia (13), hyperkalemic periodic paralysis, type 2 (13), familial periodic paralysis (12), periodic paralyses (10), native american myopathy (8), metal metabolism disorder (5), graves disease 1 (5), arrhythmogenic right ventricular cardiomyopathy (2), retinitis pigmentosa (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 49.96 RPKM in Muscle - Skeletal
Total median expression: 52.51 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -29.3087-0.337 Picture PostScript Text
3' UTR -131.40319-0.412 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR005821 - Ion_trans_dom
IPR014873 - VDCC_a1su_IQ
IPR005450 - VDCC_L_a1ssu
IPR005446 - VDCC_L_a1su
IPR002077 - VDCCAlpha1

Pfam Domains:
PF00520 - Ion transport protein
PF08016 - Polycystin cation channel
PF08763 - Voltage gated calcium channel IQ domain
PF16905 - Voltage-dependent L-type calcium channel, IQ-associated

SCOP Domains:
47473 - EF-hand
81324 - Voltage-gated potassium channels

Protein Data Bank (PDB) 3-D Structure
MuPIT help
2VAY - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on Q13698
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGDEnsembl   
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0005216 ion channel activity
GO:0005244 voltage-gated ion channel activity
GO:0005245 voltage-gated calcium channel activity
GO:0005262 calcium channel activity
GO:0005515 protein binding
GO:0005516 calmodulin binding
GO:0008331 high voltage-gated calcium channel activity
GO:0046872 metal ion binding

Biological Process:
GO:0006811 ion transport
GO:0006816 calcium ion transport
GO:0006936 muscle contraction
GO:0034765 regulation of ion transmembrane transport
GO:0055085 transmembrane transport
GO:0070588 calcium ion transmembrane transport
GO:0071313 cellular response to caffeine
GO:0086010 membrane depolarization during action potential

Cellular Component:
GO:0005737 cytoplasm
GO:0005886 plasma membrane
GO:0005891 voltage-gated calcium channel complex
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0030315 T-tubule
GO:0031674 I band
GO:0042383 sarcolemma
GO:1990454 L-type voltage-gated calcium channel complex


-  Descriptions from all associated GenBank mRNAs
  L33798 - Human dihydropyridine-sensitive L-type calcium channel alpha-1 subunit (CACNL1A3) mRNA, complete cds.
BC133671 - Homo sapiens calcium channel, voltage-dependent, L type, alpha 1S subunit, mRNA (cDNA clone MGC:149103 IMAGE:40073990), complete cds.
JD126538 - Sequence 107562 from Patent EP1572962.
JD170811 - Sequence 151835 from Patent EP1572962.
JD471222 - Sequence 452246 from Patent EP1572962.
JD131229 - Sequence 112253 from Patent EP1572962.
JD370523 - Sequence 351547 from Patent EP1572962.
JD404615 - Sequence 385639 from Patent EP1572962.
JD456653 - Sequence 437677 from Patent EP1572962.
JD197255 - Sequence 178279 from Patent EP1572962.
JD466624 - Sequence 447648 from Patent EP1572962.
JD317351 - Sequence 298375 from Patent EP1572962.
U09784 - Human skeletal muscle dihydropyridine receptor mRNA, partial cds.
AX546822 - Sequence 23 from Patent WO02063000.
U14413 - Human dihydropyridine receptor alpha 1 subunit mRNA, partial cds.
U18986 - Human dihydropyridine receptor mRNA, partial cds.
JD328457 - Sequence 309481 from Patent EP1572962.
JD185685 - Sequence 166709 from Patent EP1572962.
JD067922 - Sequence 48946 from Patent EP1572962.
JD342822 - Sequence 323846 from Patent EP1572962.
JD408980 - Sequence 390004 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein Q13698 (Reactome details) participates in the following event(s):

R-HSA-525833 NCAM1 interacts with T- and L-type VDCC
R-HSA-5577213 LTCC heteropentamer (open) transports Ca2+ from extracellular region to cytosol
R-HSA-419037 NCAM1 interactions
R-HSA-375165 NCAM signaling for neurite out-growth
R-HSA-5576892 Phase 0 - rapid depolarisation
R-HSA-5576893 Phase 2 - plateau phase
R-HSA-422475 Axon guidance
R-HSA-5576891 Cardiac conduction
R-HSA-1266738 Developmental Biology
R-HSA-397014 Muscle contraction

-  Other Names for This Gene
  Alternate Gene Symbols: A4IF51, B1ALM2, CAC1S_HUMAN, CACH1, CACN1, CACNL1A3 , ENST00000362061.1, ENST00000362061.2, ENST00000362061.3, NM_000069, Q12896, Q13698, Q13934, uc318cmt.1, uc318cmt.2
UCSC ID: ENST00000362061.4_12
RefSeq Accession: NM_000069.3
Protein: Q13698 (aka CAC1S_HUMAN or CCAS_HUMAN)

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene CACNA1S:
hpp (Hypokalemic Periodic Paralysis)
mhs (Malignant Hyperthermia Susceptibility)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.